Financials Omega Healthcare Investors, Inc.

Equities

OHI

US6819361006

Specialized REITs

Market Closed - Nyse 04:00:02 2024-04-26 pm EDT 5-day change 1st Jan Change
31.09 USD +0.61% Intraday chart for Omega Healthcare Investors, Inc. +2.20% +1.40%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,254 8,245 7,071 6,545 7,512 7,677 - -
Enterprise Value (EV) 1 14,366 13,251 12,304 11,535 12,134 12,563 12,770 12,957
P/E ratio 26.8 x 51.9 x 16.9 x 15.5 x 30.7 x 22.9 x 21.1 x 22.7 x
Yield 6.26% 7.38% 9.06% 9.59% 8.74% 8.62% 8.64% 8.69%
Capitalization / Revenue 11.7 x 11.1 x 7.76 x 8.91 x 9.27 x 9.25 x 8.7 x 8.56 x
EV / Revenue 18.2 x 17.9 x 13.5 x 15.7 x 15 x 15.1 x 14.5 x 14.4 x
EV / EBITDA 16.8 x 16.2 x 12.5 x 14.5 x 14.2 x 13.6 x 12.9 x 12.5 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 2.27 x - 1.81 x 1.72 x 2.1 x 1.85 x 1.83 x 1.8 x
Nbr of stocks (in thousands) 218,502 227,004 238,974 234,183 244,994 246,934 - -
Reference price 2 42.35 36.32 29.59 27.95 30.66 31.09 31.09 31.09
Announcement Date 2/5/20 2/4/21 2/2/22 2/2/23 2/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 791.2 740.8 910.7 734.2 810 830.3 882.9 896.8
EBITDA 1 856 820.2 985.9 793.3 853.2 923.7 991.2 1,036
EBIT 1 551.7 490.3 643.9 460.9 533.5 584.3 644.1 675.3
Operating Margin 69.74% 66.18% 70.7% 62.78% 65.87% 70.38% 72.96% 75.3%
Earnings before Tax (EBT) 1 343.8 162.3 416.1 436.1 255.6 346.2 396 399.6
Net income 1 341.1 159.3 416.7 426.9 242.2 346.2 380.3 398.6
Net margin 43.12% 21.51% 45.76% 58.15% 29.9% 41.7% 43.08% 44.45%
EPS 2 1.580 0.7000 1.750 1.800 1.000 1.359 1.473 1.369
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 2.650 2.680 2.680 2.680 2.680 2.680 2.687 2.702
Announcement Date 2/5/20 2/4/21 2/2/22 2/2/23 2/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 243.6 214.3 213.3 207.5 203.2 110.1 185.1 215 205.9 204 199.9 204.7 210.6 215 215.6
EBITDA 1 263 228.8 229.3 222.2 217 124.8 193.7 224.1 217.9 217.6 219.6 225.4 232.5 239.1 241.4
EBIT 1 176.9 143.5 146.6 139 134.3 41.11 75.58 142.1 137.1 141.9 138.2 143.3 148.9 154 153
Operating Margin 72.64% 66.97% 68.7% 66.95% 66.09% 37.32% 40.83% 66.08% 66.56% 69.56% 69.11% 70% 70.69% 71.62% 70.97%
Earnings before Tax (EBT) 1 142.3 33.71 194.8 91.25 102.1 47.99 34.72 62.08 97.01 61.82 79.99 84.75 90.02 91.65 91.8
Net income 1 138.9 33.29 189.6 89.47 102.3 45.58 35.94 59.86 91.38 55 79.9 85.31 89.61 92.64 90.05
Net margin 57.04% 15.53% 88.87% 43.11% 50.33% 41.38% 19.42% 27.84% 44.38% 26.96% 39.97% 41.67% 42.55% 43.09% 41.77%
EPS 2 0.5800 0.1400 0.7900 0.3800 0.4300 0.1900 0.1500 0.2500 0.3700 0.2200 0.3137 0.3315 0.3502 0.3622 0.3399
Dividend per Share 2 0.6700 0.6700 0.6700 0.6700 0.6700 0.6700 0.6700 0.6700 0.6700 0.6700 0.6700 0.6700 0.6700 0.6700 0.6734
Announcement Date 11/4/21 2/2/22 5/2/22 8/1/22 11/2/22 2/2/23 5/2/23 8/2/23 11/2/23 2/7/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 5,112 5,006 5,233 4,990 4,623 4,886 5,093 5,280
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 5.972 x 6.103 x 5.308 x 6.289 x 5.418 x 5.29 x 5.138 x 5.098 x
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 10.3% 3.99% 10.8% 11.4% 6.74% 9.06% 10.3% 11.4%
ROA (Net income/ Total Assets) 4.25% - - - 2.62% 3.23% 3.41% 3.58%
Assets 1 8,019 - - - 9,261 10,719 11,148 11,135
Book Value Per Share 2 18.60 - 16.30 16.20 14.60 16.80 17.00 17.30
Cash Flow per Share 2 - - 2.960 2.560 - 2.840 3.010 3.130
Capex 1 - - - - - 11.9 12.5 -
Capex / Sales - - - - - 1.43% 1.42% -
Announcement Date 2/5/20 2/4/21 2/2/22 2/2/23 2/7/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
31.09 USD
Average target price
32.92 USD
Spread / Average Target
+5.90%
Consensus
  1. Stock Market
  2. Equities
  3. OHI Stock
  4. Financials Omega Healthcare Investors, Inc.